Treatment of metabolic syndrome with norfluoxetine

摘要

The invention relates to methods of treating metabolic syndrome, or the specific disorders associated with metabolic syndrome, comprising the administration of norfluoxetine enriched for the (R) or (S) enantiomer conjointly with niacin, fenofibrate, a H₁ antagonist or inverse agonist, or a H₃ agonist or partial agonist.